Amaurosis fugax.
Pryse-Phillips W.
Br Med J (Clin Res Ed). 1982 Oct 16;285(6348):1066-8. doi: 10.1136/bmj.285.6348.1066.
Hypnic Amaurosis Fugax.
Thoveson A, Baig IF, Mortensen PW, Lee AG.
J Neuroophthalmol. 2022 Mar 1;42(1):e357-e358. doi: 10.1097/WNO.0000000000001315. Epub 2022 Jan 17.
Amaurosis Fugax.
Kaur K, Najem K, Margolin E.
2025 Jan 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
[Amaurosis fugax].
Nicolaescu MM.
Oftalmologia. 2009;53(3):46-54.
Oxaliplatin-Associated Amaurosis Fugax.
Kubo K, Kimura N, Watanabe R, Higashino M, Tsuda M, Kato M.
Case Rep Oncol. 2021 Jun 11;14(2):832-837. doi: 10.1159/000516271. eCollection 2021 May-Aug.
Amaurosis fugax.
[No authors listed]
Lancet. 1982 Apr 10;1(8276):838-9.
Amaurosis fugax.
Gautier JC.
N Engl J Med. 1993 Aug 5;329(6):426-8. doi: 10.1056/NEJM199308053290611.
Amaurosis fugax.
Pasic M, Carrel T, Turina M.
N Engl J Med. 1994 Jan 13;330(2):143-4. doi: 10.1056/NEJM199401133300216.
Amaurosis fugax. An overview.
Burde RM.
J Clin Neuroophthalmol. 1989 Sep;9(3):185-9.
Transient Monocular Visual Loss (Amaurosis Fugax): How Does Age Impact Diagnosis?
Douglas VP, Rachapudi SS, Davila-Siliezar P, Laylani NAR, Lee AG.
Ophthalmol Ther. 2024 Jun;13(6):1417-1425. doi: 10.1007/s40123-024-00932-z. Epub 2024 Apr 8.
